These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2327502)

  • 21. Neuroleptic malignant syndrome, bromocriptine, and anticholinergic drugs.
    Schvehla TJ; Herjanic M
    J Clin Psychiatry; 1988 Jul; 49(7):283-4. PubMed ID: 3391983
    [No Abstract]   [Full Text] [Related]  

  • 22. Management of extrapyramidal side effects induced by neuroleptics.
    Tune LE; McHugh PR; Coyle JT
    Johns Hopkins Med J; 1981 Mar; 148(3):149-53. PubMed ID: 7206408
    [No Abstract]   [Full Text] [Related]  

  • 23. Essential myoclonus: response to anticholinergic therapy.
    Duvoisin RC
    Clin Neuropharmacol; 1984; 7(2):141-7. PubMed ID: 6733693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics.
    Winslow RS; Stillner V; Coons DJ; Robison MW
    Am J Psychiatry; 1986 Jun; 143(6):706-10. PubMed ID: 2872822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benztropine psychosis.
    Ananth JV; Jain RC
    Can Psychiatr Assoc J; 1973 Oct; 18(5):409-14. PubMed ID: 4746144
    [No Abstract]   [Full Text] [Related]  

  • 26. Replacement of chronically administered anticholinergic drugs by amantadine in outpatient management of chronic schizophrenia.
    McEvoy JP; McCue M; Freter S
    Clin Ther; 1987; 9(4):429-33. PubMed ID: 2886223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of benztropine therapy for drooling.
    Camp-Bruno JA; Winsberg BG; Green-Parsons AR; Abrams JP
    Dev Med Child Neurol; 1989 Jun; 31(3):309-19. PubMed ID: 2666205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of drug-induced priapism in a gelding by medication.
    Sharrock AG
    Aust Vet J; 1982 Jan; 58(1):39-40. PubMed ID: 7082233
    [No Abstract]   [Full Text] [Related]  

  • 29. Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs.
    Haldeman S; Goldman JW; Hyde J; Pribram HF
    Neurology; 1981 Apr; 31(4):442-5. PubMed ID: 7194433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug.
    Singh MM; Smith JM
    J Nerv Ment Dis; 1973 Jul; 157(1):50-8. PubMed ID: 4713306
    [No Abstract]   [Full Text] [Related]  

  • 31. Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance.
    Singh MM; Kay SR
    J Nerv Ment Dis; 1975 Apr; 160(4):258-66. PubMed ID: 1097596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of akathisia in a severely retarded adolescent male with help of an anticholinergic drug assay.
    Harris JC; Tune LE; Allen M; Coyle JT
    Lancet; 1981 Aug; 2(8243):414. PubMed ID: 6115172
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug-induced acute dystonic reactions in children. Alternatives to diphenhydramine therapy.
    Dahiya U; Noronha P
    Postgrad Med; 1984 Apr; 75(5):286-7, 290. PubMed ID: 6143309
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics.
    Klett CJ; Caffey E
    Arch Gen Psychiatry; 1972 Apr; 26(4):374-9. PubMed ID: 4552131
    [No Abstract]   [Full Text] [Related]  

  • 35. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures.
    Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J
    Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cholinergic agents in Huntington's disease: a reappraisal.
    Nutt JG
    Neurology; 1983 Jul; 33(7):932-5. PubMed ID: 6223236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus.
    Chokroverty S; Manocha MK; Duvoisin RC
    Neurology; 1987 Apr; 37(4):608-15. PubMed ID: 3561772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced parkinsonism.
    Kelly JT; Zimmermann RL; Abuzzahab FS; Schiele BC
    Pharmacology; 1974; 12(2):65-73. PubMed ID: 4610599
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of catatonia with an anticholinergic agent.
    Albucher RC; DeQuardo J; Tandon R
    Biol Psychiatry; 1991 Mar; 29(5):513-4. PubMed ID: 2018827
    [No Abstract]   [Full Text] [Related]  

  • 40. The withdrawal of benztropine mesylate in chronic schizophrenic patients.
    Baker LA; Cheng LY; Amara IB
    Br J Psychiatry; 1983 Dec; 143():584-90. PubMed ID: 6362765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.